ZA200904963B - Uses and methods for preventing and/or treating caries caused by mutants Streptococci - Google Patents

Uses and methods for preventing and/or treating caries caused by mutants Streptococci

Info

Publication number
ZA200904963B
ZA200904963B ZA200904963A ZA200904963A ZA200904963B ZA 200904963 B ZA200904963 B ZA 200904963B ZA 200904963 A ZA200904963 A ZA 200904963A ZA 200904963 A ZA200904963 A ZA 200904963A ZA 200904963 B ZA200904963 B ZA 200904963B
Authority
ZA
South Africa
Prior art keywords
preventing
methods
treating caries
caries caused
streptococci
Prior art date
Application number
ZA200904963A
Other languages
English (en)
Inventor
Andreas Reindl
Christine Lang
Mewes Boettner
Markus Veen
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of ZA200904963B publication Critical patent/ZA200904963B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00—Chewing gum
    • A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/123—Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/366—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA200904963A 2006-12-19 2009-07-16 Uses and methods for preventing and/or treating caries caused by mutants Streptococci ZA200904963B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06026301 2006-12-19

Publications (1)

Publication Number Publication Date
ZA200904963B true ZA200904963B (en) 2010-09-29

Family

ID=39414932

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200904963A ZA200904963B (en) 2006-12-19 2009-07-16 Uses and methods for preventing and/or treating caries caused by mutants Streptococci

Country Status (12)

Country Link
US (1) US20100047190A1 (de)
EP (1) EP2094830B1 (de)
JP (2) JP5277172B2 (de)
KR (1) KR101432336B1 (de)
CN (2) CN101563447A (de)
AU (1) AU2007334850C1 (de)
BR (1) BRPI0719279B1 (de)
CA (1) CA2671507A1 (de)
ES (1) ES2417132T3 (de)
RU (1) RU2446208C9 (de)
WO (1) WO2008074473A2 (de)
ZA (1) ZA200904963B (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2527940C (en) 2003-06-03 2016-03-22 Richard L. Veech Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
WO2010045367A1 (en) * 2008-10-14 2010-04-22 Dr Pepper/Seven Up, Inc. Shelf-stable consumable compositions containing probiotic-mimicking elements and methods of preparing and using the same
GB0820259D0 (en) * 2008-11-05 2008-12-10 Mars Inc Composition
KR20120112452A (ko) * 2009-11-10 2012-10-11 바스프 에스이 건강 증진용 제제 및 제조 방법
GB201002983D0 (en) * 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
GB2482536B (en) 2010-08-05 2013-07-24 Hera Pharmaceuticals Inc Expression of antibody or a fragment thereof in lactobacillus
US8591882B2 (en) * 2010-08-27 2013-11-26 Kabushiki Kaisha Yakult Honsha Cytoprotective agent
WO2012060312A1 (ja) * 2010-11-05 2012-05-10 国立大学法人広島大学 籾殻または玄米から単離された植物乳酸菌およびその利用
KR20140000710A (ko) * 2011-01-24 2014-01-03 바스프 에스이 구강 건강 증진 조성물
CN102250603B (zh) * 2011-05-06 2013-06-26 河北科技大学 一种分段注入式油井复合解堵剂及其注入方法
EP2710115B1 (de) * 2011-05-16 2017-12-27 Belano Medical AG Neue milchsäurebakterien und diese enthaltende zusammensetzungen gegen bakterielle erkältungen
JP5982376B2 (ja) * 2011-08-05 2016-08-31 株式会社ヤクルト本社 口腔内疾患の予防又は治療剤
ES2752030T3 (es) 2012-11-05 2020-04-02 Us Health Cuerpos cetónicos para proteger los tejidos del daño por radiación ionizante
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
AU2014230120B2 (en) 2013-03-14 2018-06-21 Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Process for producing (R)-3hydroxybutyl (R)-3hydroxybutyrate
AU2014314537B2 (en) * 2013-09-02 2019-08-15 Société des Produits Nestlé S.A. Lactoferrin and memory and learning speed in children
CN104673700A (zh) * 2013-11-29 2015-06-03 晨晖生物科技股份有限公司 乳酸菌株及引物组
WO2017072285A1 (en) * 2015-10-28 2017-05-04 Mirnagreen S.R.L. Methods for extracting bioactive small rnas from plants and mushrooms
EP3405205B1 (de) 2016-01-19 2020-07-15 Symrise AG Probiotika zur verwendung als entzündungshemmende wirkstoffe in der mundhöhle
EP3196318A1 (de) * 2016-01-19 2017-07-26 Symrise AG Probiotika zum ändern der zusammensetzung von oralen biofilmen
MX2018012671A (es) * 2016-04-21 2019-03-07 Quantec Ltd Combinacion, usos terapeuticos y usos profilacticos.
JP6658265B2 (ja) * 2016-04-26 2020-03-04 ライオン株式会社 インビトロバイオフィルムモデルの製造方法、ならびに評価方法及び口腔用組成物を選定する方法
CN106173170A (zh) * 2016-06-30 2016-12-07 杭州贝因美豆逗儿童营养食品有限公司 一种防龋齿棒棒糖及其制备方法
EP3351259A1 (de) 2017-01-18 2018-07-25 Symrise AG Probiotika zur aggregation mit krankheitsassoziierten spezies in der mundhöhle
RU2685492C1 (ru) * 2017-12-27 2019-04-18 Федеральное государственное бюджетное образовательное учреждение высшего образования "Дальневосточный государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ДВГМУ Минздрава России) Способ профилактики кариеса зубов у детей раннего возраста воздействием на управляемые факторы риска его развития
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
US11147845B2 (en) 2018-07-16 2021-10-19 ProBiora Health, LLC Foods containing beneficial oral bacteria
CN108936256B (zh) * 2018-07-25 2023-07-21 南宁职业技术学院 米粉压榨机
CN110257297B (zh) * 2019-07-02 2020-12-25 内蒙古蒙牛乳业（集团）股份有限公司 一株分离的用于促进口腔健康的副干酪乳杆菌pc-01及其应用
KR102217518B1 (ko) * 2020-08-18 2021-02-19 주식회사 메디오젠 치주염 예방 또는 치료용 유산균 및 그의 용도
KR102217525B1 (ko) * 2020-08-18 2021-02-19 주식회사 메디오젠 치주염 예방 또는 치료용 유산균 및 그의 용도
WO2022192453A1 (en) * 2021-03-11 2022-09-15 Benova Rx LLC Compositions and methods of use thereof for antiseptic mouth rinses

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946725A (en) 1957-03-25 1960-07-26 Procter & Gamble Dentifrice compositions
US3678154A (en) 1968-07-01 1972-07-18 Procter & Gamble Oral compositions for calculus retardation
US3535421A (en) 1968-07-11 1970-10-20 Procter & Gamble Oral compositions for calculus retardation
BE757004A (fr) 1969-10-03 1971-03-16 Gore & Ass Agent d'etancheite
CA962021A (en) 1970-05-21 1975-02-04 Robert W. Gore Porous products and process therefor
US3962153A (en) 1970-05-21 1976-06-08 W. L. Gore & Associates, Inc. Very highly stretched polytetrafluoroethylene and process therefor
GB1373487A (en) 1970-10-26 1974-11-13 Guggenheim B Enzymes their preparation and uses
US3800812A (en) 1972-11-27 1974-04-02 Pauldan Ind Inc Dental floss and method of making same
US3959458A (en) 1973-02-09 1976-05-25 The Procter & Gamble Company Oral compositions for calculus retardation
US4096227A (en) 1973-07-03 1978-06-20 W. L. Gore & Associates, Inc. Process for producing filled porous PTFE products
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements
US4083955A (en) 1975-04-02 1978-04-11 The Procter & Gamble Company Processes and compositions for remineralization of dental enamel
US4051234A (en) 1975-06-06 1977-09-27 The Procter & Gamble Company Oral compositions for plaque, caries, and calculus retardation with reduced staining tendencies
US4206215A (en) 1976-02-25 1980-06-03 Sterling Drug Inc. Antimicrobial bis-[4-(substituted-amino)-1-pyridinium]alkanes
US4256806A (en) 1979-07-05 1981-03-17 W. L. Gore & Associates, Inc. Smudge free graphite coated polymeric substrate and a method for preparing the same
US4478665A (en) 1980-11-06 1984-10-23 W. L. Gore & Associates, Inc. Method for manufacturing highly porous, high strength PTFE articles
US4385093A (en) 1980-11-06 1983-05-24 W. L. Gore & Associates, Inc. Multi-component, highly porous, high strength PTFE article and method for manufacturing same
US4885155A (en) 1982-06-22 1989-12-05 The Procter & Gamble Company Anticalculus compositions using pyrophosphate salt
US4849213A (en) 1983-03-01 1989-07-18 Schaeffer Hans A Dental preparation, article and method for storage and delivery therof
CA1262442A (en) * 1984-03-09 1989-10-24 Yasuo Kawai Anticariogenic or antiperiodontitic agent
DE3645147C2 (de) 1985-09-13 2000-11-09 Colgate Palmolive Co Zahnpflegemittel
US4776358A (en) 1986-09-23 1988-10-11 Leonard Lorch Floss employing microporous tapes sandwiching paste dentifrice
US4894220A (en) 1987-01-30 1990-01-16 Colgate-Palmolive Company Antibacterial antiplaque oral composition
EP0311469A3 (de) 1987-09-02 1990-05-30 Plant Genetic Systems N.V. Transformierte Milchsäurebakterien
US5004597A (en) 1987-09-14 1991-04-02 The Procter & Gamble Company Oral compositions comprising stannous flouride and stannous gluconate
US5209251A (en) 1988-03-29 1993-05-11 Colgate-Palmolive Company Dental floss
US5033488A (en) 1988-03-29 1991-07-23 Colgate-Palmolive Co. Dental floss
US4974615A (en) 1989-07-26 1990-12-04 Doundoulakis George J Elastic filament for oral hygiene
NZ235489A (en) 1989-10-16 1992-03-26 Colgate Palmolive Co Articles for therapeutic (e.g. dental) use having a polytetrafluoroethylene surface which is coated with an adjuvant and a partially water-soluble binder
US5760117A (en) 1990-05-21 1998-06-02 Applied Elastomerics, Inc. Gelatinous composition and articles
US5884639A (en) 1996-03-08 1999-03-23 Applied Elastomerics, Inc. Crystal gels with improved properties
US5015466A (en) 1990-06-26 1991-05-14 The Procter & Gamble Company Anticalculus compositions using tartrate-succinates
US5220932A (en) 1990-12-20 1993-06-22 Westone Products Limited Dental floss and method of making it
US5281410A (en) 1991-10-23 1994-01-25 The Proctor & Gamble Company Methods of reducing plaque and gingivitis with reduced staining
US5213790A (en) 1991-10-23 1993-05-25 The Procter & Gamble Co. Methods of reducing plaque and gingivitis with reduced staining
US5145666A (en) 1991-10-23 1992-09-08 The Proctor & Gamble Co. Methods of reducing plaque and gingivitis with reduced staining
GB9126686D0 (en) 1991-12-17 1992-02-12 Smithkline Beecham Plc Novel compositions
US5407623A (en) 1994-01-06 1995-04-18 Polteco, Inc. Process for obtaining ultra-high modulus line products with enhanced mechanical properties
US5433226A (en) 1994-03-09 1995-07-18 Delta Dental Hygienics, L.L.C. Dental floss based on robust segmented elastomer
US5872001A (en) 1994-04-20 1999-02-16 Uab Research Foundation Lanthionine antibiotic compositions and methods
US5518012A (en) 1994-06-15 1996-05-21 W. L. Gore & Associates, Inc. Expanded PTFE floss material and method of making same
GB9501826D0 (en) 1995-01-31 1995-03-22 St Thomas Hosp Med School Polypeptide fragments
US6027592A (en) 1995-06-06 2000-02-22 Gillette Canada Inc. Dental floss
US5718251A (en) 1996-04-26 1998-02-17 W. L. Gore & Associates, Inc. Dental floss article
US5755243A (en) 1996-06-27 1998-05-26 Gillette Canada, Inc. Dental floss with thermoplastic coating
US5911228A (en) 1996-07-10 1999-06-15 Colgate-Palmolive Co. Ingredient filled polytetrafluoroethylene dental floss devoid to grip enhancing coating
US5932469A (en) 1997-06-10 1999-08-03 University Of Florida Antimicrobial polypeptide, nucleic acid, and methods of use
KR19990024297A (ko) 1997-08-07 1999-04-06 오종석 인체 구강내 치태형성을 억제하는 신규한 유산균
US6003525A (en) 1998-03-14 1999-12-21 Katz; Harry S. Elastomer floss and related flossing devices
US6270781B1 (en) 1999-01-08 2001-08-07 Maxim Pharmaceuticals, Inc. Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
WO2000066616A1 (en) 1999-05-03 2000-11-09 Advanced Research & Technology Institute, Inc. METHODS AND COMPOSITIONS FOR CONTROLLING DENTAL CARIES, AND RECOMBINANT SmaA POLYPEPTIDES USEFUL FOR SAME
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
DE19947620A1 (de) 1999-10-04 2001-04-05 Valeo Auto Electric Gmbh Wischeinrichtung
AU772224B2 (en) * 1999-10-12 2004-04-22 Blis Technologies Limited Lantibiotic
AU776045B2 (en) 2000-01-19 2004-08-26 Bridgestone Corporation Rubber crawler
EP1133046A3 (de) 2000-03-02 2002-02-27 Moriyama Kogyo Kabushiki Kaisha Generator mit mehrpoliger magnetischer Erregung für Verbrennungskraftmaschinen
CA2302861A1 (en) 2000-04-10 2001-10-10 Dennis G. Cvitkovitch Signal peptides nucleic acid molecules and methods for treatment of caries
AU6901501A (en) * 2000-06-13 2001-12-24 Unilever Plc Non-viable lactobacillus containing food product
US6342385B1 (en) 2000-07-28 2002-01-29 The Uab Research Foundation Mutacin I biosynthesis genes and proteins
JP3944076B2 (ja) * 2000-08-25 2007-07-11 わかもと製薬株式会社 乳酸菌含有プロバイオティクス製品
JP2004533859A (ja) 2001-01-22 2004-11-11 インターナシヨナル・テープ・パートナーズ・エル・エル・シー エラストマー単繊維デンタルテープ用の結晶を含まない唾液溶解性コーティング
US6591844B2 (en) 2001-01-22 2003-07-15 Peri-Deat Limited Elastomeric monofilament dental tapes
EP1236463B1 (de) * 2001-02-23 2007-01-03 Chemisches Laboratorium Dr. Kurt Richter GmbH Zusammensetzung zur topischen Anwendung
US6770264B2 (en) 2001-11-13 2004-08-03 Noville, Inc. Chewing gum compositions comprising diglycerol
US6612809B2 (en) 2001-11-28 2003-09-02 General Electric Company Thermally compliant discourager seal
US20040057908A1 (en) 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
KR100356672B1 (ko) * 2001-12-27 2002-10-19 주식회사 바이로박트 신규한 락토바실러스 속 미생물 및 그 용도
AU2003279247A1 (en) 2002-06-21 2004-01-06 New Horizons Diagnostics Corporation The use of bacterial phage associated lysing proteins for treating bacterial dental caries
DE10237317B4 (de) 2002-08-15 2010-04-08 3M Espe Ag Enzymhaltige Zusammensetzung, Verfahren zu deren Herstellung und deren Verwendung
US20040101495A1 (en) * 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
US6872565B2 (en) * 2003-01-29 2005-03-29 Biogaia Ab Product containing Lactobacillus reuteri strain ATTC PTA-4965 or PTA-4964 for inhibiting bacteria causing dental caries
US20050125036A1 (en) 2003-08-14 2005-06-09 Mark Roby Heterogeneous yarns for surgical articles
EP1634948A1 (de) * 2004-09-10 2006-03-15 Basf Aktiengesellschaft Mittel und Verfahren zur Vorbeugung und/oder Behandlung von Karies
DK1934327T3 (da) * 2005-09-13 2013-04-15 Organobalance Gmbh Mikroorganismer, der hæmmer dannelsen af armhulelugt
TW200808191A (en) * 2006-08-09 2008-02-16 Genmont Biotech Inc Product containing Lactobacillus paracasei
KR20120112452A (ko) * 2009-11-10 2012-10-11 바스프 에스이 건강 증진용 제제 및 제조 방법

Also Published As

Publication number Publication date
CA2671507A1 (en) 2008-06-26
KR101432336B1 (ko) 2014-08-20
JP5277172B2 (ja) 2013-08-28
RU2009127513A (ru) 2011-01-27
JP2010513350A (ja) 2010-04-30
US20100047190A1 (en) 2010-02-25
CN101563447A (zh) 2009-10-21
JP5721765B2 (ja) 2015-05-20
WO2008074473A2 (en) 2008-06-26
EP2094830B1 (de) 2013-04-10
WO2008074473A3 (en) 2008-10-16
ES2417132T3 (es) 2013-08-06
RU2446208C9 (ru) 2012-11-10
AU2007334850A1 (en) 2008-06-26
KR20090096724A (ko) 2009-09-14
BRPI0719279A2 (pt) 2014-03-11
CN104814983A (zh) 2015-08-05
BRPI0719279B1 (pt) 2018-12-04
AU2007334850B2 (en) 2012-06-14
RU2446208C2 (ru) 2012-03-27
EP2094830A2 (de) 2009-09-02
JP2013151534A (ja) 2013-08-08
AU2007334850C1 (en) 2014-02-13

Similar Documents

Publication Publication Date Title
ZA200904963B (en) Uses and methods for preventing and/or treating caries caused by mutants Streptococci
EP1959929A4 (de) Zusammensetzungen und verfahren zur behandlung dermatologischer leiden
ZA200901615B (en) Compositions and methods for diagnosing and treating cancer
EP2032166A4 (de) Zusammensetzungen und verfahren zur diagnostizierung und behandlung von krebs
HK1114350A1 (en) An extract for preventing or treating thrombotic diseases
EP1945754A4 (de) Zusammensetzungen und verfahren zur behandlung und diagnostizierung von krebs
HK1179275A1 (en) Compositions and methods for diagnosing and treating cancer
IL185540A0 (en) Compositions and methods for treating acne
EP1940437A4 (de) Zusammensetzungen und verfahren zur behandlung von bakterien
IL186963A0 (en) Methods and compositions for treating pain
EP1890712A4 (de) Zusammensetzungen und verfahren zur behandlung von schmerzen
EP2081437A4 (de) Verfahren zur bekämpfung oder vorbeugung von schädlingsbefall
EP2069391A4 (de) Zusammensetzungen und verfahren zur behandlung oder prävention von augenleiden
EP2101567A4 (de) Zusammensetzungen und verfahren zur erkennung, behandlung oder prävention von reduktivem stress
EP2099491A4 (de) Zusammensetzungen und verfahren zur behandlung und diagnostizierung von krebs
GB0718918D0 (en) Compositions and methods for treating skin conditions
HK1129596A1 (en) Methods and compositions for treating disease
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
EP2326340A4 (de) Zusammensetzungen und verfahren zur behandlung von pneumokokkeninfektionen
EP2012825A4 (de) Verfahren und zusammensetzungen zur prävention und behandlung von infektionen mit streptococcus pneumoniae
EP2328611A4 (de) Zusammensetzungen und verfahren zur behandlung von s.pneumoniae-infektion
IL194372A0 (en) Methods and compositions for preventing and treating streptococcus pneumoniae infection
GB0620693D0 (en) Composition and methods for the treatment of degenerative disease
IL188166A0 (en) Methods for treating dermatitis using mutant human il-4 compositions
GB0522732D0 (en) Composition and method for treating disease